iifl-logo

Syncom Formulations India Ltd Share Price Live

Add as a Preferred Source on Google
₹20.2
(-3.26%)
Nov 6, 2026|03:59:05 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Equities

Futures

Option

  • Open₹20.78
  • Day's High₹21.18
  • 52 Wk High₹27.49
  • Prev. Close₹20.88
  • Day's Low₹19.8
  • 52 Wk Low ₹10.21
  • Turnover (lac)1,465.35
  • P/E23.19
  • Face Value₹1
  • Book Value₹4.65
  • EPS0.9
  • Mkt. Cap (Cr.)₹1,898.8
  • Div. Yield0.48
View All Historical Data

No Record Found

No Record Found

Syncom Formulations India Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

₹20.78

Prev. Close

₹20.88

Turnover(Lac.)

₹1,465.35

Day's High

₹21.18

Day's Low

₹19.8

52 Week's High

₹27.49

52 Week's Low

₹10.21

Book Value

₹4.65

Face Value

₹1

Mkt Cap (₹ Cr.)

1,898.8

P/E

23.19

EPS

0.9

Divi. Yield

0.48

Syncom Formulations India Ltd Corporate Action

11 Aug 2026

12:00 AM

AGM

Announcement Date: 11 Aug, 2026

arrow

8 Aug 2025

12:00 AM

BookCloser

arrow

6 Aug 2026

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

11 Aug 2026

12:00 AM

Dividend

Dividend Amount: 0.1

Record Date: 23 Sep, 2026

arrow

Syncom Formulations (India) Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Knowledge Center

Demat Account

View More

Trading Account

View More

Syncom Formulations (India) Ltd SHAREHOLDING SNAPSHOT

06 Nov, 2026|06:30 PM
Sep-2026Jun-2026Mar-2026Dec-2025
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 50.56%

Foreign: 0.00%

Indian: 50.56%

Non-Promoter- 2.22%

Institutions: 2.22%

Non-Institutions: 47.20%

Custodian: 0.00%

Read More
Share PriceShare Price

Syncom Formulations India Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2026Mar-2025Mar-2024Mar-2023

Equity Capital

94

94

94

94

Preference Capital

0

0

0

0

Reserves

318.3

245.9

192.45

162.01

Net Worth

412.3

339.9

286.45

256.01

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

244.8

205.51

158.63

184.82

yoy growth (%)

19.12

29.55

-14.17

0.5

Raw materials

-161.46

-151.62

-108.94

-128.11

As % of sales

65.95

73.77

68.68

69.31

Employee costs

-19.66

-16.29

-15.04

-14.49

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

40.67

17.34

12.11

16

Depreciation

-4.03

-4.06

-3.72

-3.12

Tax paid

-11.53

-3.03

-3.36

-5.34

Working capital

84.97

9.2

8.52

11.14

Other operating items

View Cash Flow
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

19.12

29.55

-14.17

0.5

Op profit growth

127.39

42.55

-28.62

-1.5

EBIT growth

130.01

43.76

-24.08

0.23

Net profit growth

104.66

64.83

-18.82

2.86

View Ratios
Particulars (Rupees in Crores.)Mar-2026Mar-2025Mar-2024Mar-2023Mar-2022

Gross Sales

489.17

465.01

263.39

224.25

219.66

Excise Duty

0

0

0

0

0

Net Sales

489.17

465.01

263.39

224.25

219.66

Other Operating Income

0

0

0

0

0

Other Income

31.38

17.44

13.53

14.61

12.02

Syncom Formulations India Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,829

125.454,37,962.61871.290.886,056.5997.38

Divis Laboratories Ltd

DIVISLAB

10,140.5

89.942,69,450.618910.32,974629.49

Torrent Pharmaceuticals Ltd

TORNTPHARM

4,710

92.091,79,455.654980.724,063479.96

Laurus Labs Ltd

LAURUSLABS

2,346

121.251,26,703.22388.130.092,014.11108.87

Zydus Lifesciences Ltd

ZYDUSLIFE

1,193

37.251,19,341.36714.50.083,362.3235.81

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

View All Peer Comparision

MORE ABOUT Syncom Formulations India Ltd

Management

Register Office

Registrar Office

Independent Non Exe. Director

Ruchi Jindal

Independent Non Exe. Director

Ritesh Kumar Lunkad

Independent Non Exe. Director

Ankit Jain

Chairman / Executive Director / WTD

ANKIT KEDARMAL BANKDA

Company Sec. & Compli. Officer

Vaishali Agrawal

Managing Director &Addtnl Dir.

Rahul Vijay Bankda

WTD & Additional Director

Rinki Ankit Bankda

Registered Office

7 Niraj Indl Estate Andheri(E),

Off Mahakali Caves Rd,

Maharashtra - 400093

Tel: 91-22-30887744

Website: http://www.syncomformulations.com

Email: finance@sfil.in; sfil87@syncomformulations.com

Registrar Office

Plot No. 60,

Electronic Complex, Pardeshipura,

Indore - 452010

Tel: 91-0731-3198601/3198

Website: www.ankitonline.org

Email: ankit_4321@yahoo.com

Summary

Incorporated as a private limited Company in 1988, Syncom Formulations (India) Limited was converted into a public limited Company in June, 1992.. The Company is considered as a Global Pharmaceutical ...
Read More

Reports by Syncom Formulations India Ltd

Company FAQs

The Syncom Formulations India Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹20.2 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Syncom Formulations India Ltd is ₹1898.80 Cr. as of 06 Nov ‘26
The PE and PB ratios of Syncom Formulations India Ltd is 23.19 and 4.76 as of 06 Nov ‘26
The 52-week high/low is the highest and lowest price at which a Syncom Formulations India Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Syncom Formulations India Ltd is ₹10.21 and ₹27.49 as of 06 Nov ‘26
Syncom Formulations India Ltd's CAGR for 5 Years at 20.85%, 3 Years at 31.65%, 1 Year at 29.77%, 6 Month at 48.72%, 3 Month at 56.64% and 1 Month at -9.77%.
The shareholding pattern of Syncom Formulations India Ltd is as follows:
Promoters - 50.57 %
Institutions - 2.23 %
Public - 47.20 %

QUICKLINKS FOR Syncom Formulations India Ltd

Information
Share PriceFutures PriceOption ChainHistorical Data
Financials
Profit & LossBalance SheetCash FlowKey Ratios
Results
Quarterly ResultHalf Yearly ResultNine Monthly ResultAnnual Result
News
Company
Market
Derivatives
IPO
Mutual Funds
Calculators
Nifty 50
Company
Knowledge Center
News
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

About
IIFL Group
Products & Services
Trading Documentation
Useful Links
For Investors

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.